COVID-19 Response Plan

The purpose of this response plan is to outline guidelines for returning to school following federal, state and local recommendations. These guidelines have been carefully considered to address and promote the safety, health and welfare of our partner Lutheran school communities, students, faculty and staff.

COVID-19 recommendations are ever-changing as additional information is shared by local and state health departments and state and national regulatory agencies which, in turn, will change practices; therefore, this document will remain nimble and fluid to allow LASE to respond to these potential changes.

Reopening requires all of us to work in collaboration with one another, using recommended best practices and maintaining safe daily habits in order to reduce our risk of exposure to COVID-19. Remember: we’re all in this together!

Every child with a disability is entitled to an appropriate education and is entitled to special education services based on their individualized education plan (IEP), LASE Supportive Individual Plan (SIP) or other education plan put in place so students can reach their God-given potential. Students receiving LASE services may be more negatively affected by distance-learning and may be disproportionally impacted by interruptions in the classroom. It is our goal at LASE to continue to meet the complex needs of individual students with special learning needs and create solutions on a case-by-case basis.

The LASE standard remains consistent with the policy to provide special education programming in a parallel manner to partner schools we serve. LASE recognizes that each partner school in the Association will have a different set of standards and practices as dictated by the Partner school board, and influenced by local public school districts and local governments (STL city/county, Jefferson County, St. Charles County.) and the CDC.

This Response Plan is created as an addendum to “Back to School” and “Re-opening Plans” of our Lutheran Schools in response to COVID-19.